Literature DB >> 20231008

Angiogenic imbalances: the obstetric perspective.

Jimmy Espinoza1, John E Uckele, Robert A Starr, David E Seubert, Andres F Espinoza, Stanley M Berry.   

Abstract

Clinical and experimental evidence indicates that angiogenic imbalances may participate in the mechanisms of disease of several pregnancy complications, some of which may be life threatening. This article reviews current evidence in support of this view and the possibility that the fetus may play a central role in these imbalances; it also reviews recent experimental observations that modulation of angiogenic imbalances during pregnancy may have prophylactic and/or therapeutic value. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Mesh：

Substances：

Year:  2010        PMID： 20231008     DOI： 10.1016/j.ajog.2009.10.891

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  13 in total

1.  Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta.

Authors:  Wen Wang; Lin Feng; Honghai Zhang; Stephanie Hachy; Seiro Satohisa; Louise C Laurent; Mana Parast; Jing Zheng; Dong-bao Chen
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

2.  Inhibition of blood-brain barrier efflux transporters promotes seizure in pregnant rats: Role of circulating factors.

Authors:  Abbie C Johnson; Erica S Hammer; Sophie Sakkaki; Sarah M Tremble; Gregory L Holmes; Marilyn J Cipolla
Journal:  Brain Behav Immun       Date:  2017-07-21       Impact factor: 7.217

Review 3.  Low molecular weight heparin for the prevention of severe preeclampsia: where next?

Authors:  Kelsey McLaughlin; Ralph R Scholten; John D Parker; Enrico Ferrazzi; John C P Kingdom
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

4.  The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.

Authors:  Malou P H Schreurs; Emily M Houston; Victor May; Marilyn J Cipolla
Journal:  FASEB J       Date:  2011-09-12       Impact factor: 5.191

5.  The role of angiogenic markers in adverse perinatal outcomes: fresh versus frozen embryo transfers.

Authors:  Irene Woo; Yen Chan; Intira Sriprasert; Kristin Louie; Sue Ingles; Frank Stanczyk; Lynda K McGinnis; Karine Chung
Journal:  J Assist Reprod Genet       Date:  2017-09-04       Impact factor: 3.412

6.  Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta.

Authors:  Carlos A Labarrere; Hector L DiCarlo; Elaine Bammerlin; James W Hardin; Yeon M Kim; Piya Chaemsaithong; David M Haas; Ghassan S Kassab; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2016-12-27       Impact factor: 8.661

7.  Midpregnancy levels of angiogenic markers in relation to maternal characteristics.

Authors:  Renée S Mijal; Claudia B Holzman; Sarosh Rana; S Ananth Karumanchi; Jianling Wang; Alla Sikorskii
Journal:  Am J Obstet Gynecol       Date:  2010-12-10       Impact factor: 8.661

8.  Placental growth factor blunts uterine artery responses to angiotensin II.

Authors:  J Espinoza; A Betancourt; M A Belfort; A A Shamshirsaz; K A Fox; C Yallampalli
Journal:  BJOG       Date:  2019-03-18       Impact factor: 6.531

Review 9.  Pre-eclampsia and the foetus: a cardiovascular perspective.

Authors:  Ismail Bhorat
Journal:  Cardiovasc J Afr       Date:  2018 Nov/Dec       Impact factor: 0.802

10.  Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.

Authors:  Carmen Rădulescu; Anca Bacârea; Adina Huțanu; Rozalia Gabor; Minodora Dobreanu
Journal:  Mediators Inflamm       Date:  2016-10-05       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.